These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 19200882)

  • 1. Monitoring mammalian target of rapamycin (mTOR) activity.
    Ikenoue T; Hong S; Inoki K
    Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.
    Gibbons JJ; Abraham RT; Yu K
    Semin Oncol; 2009 Dec; 36 Suppl 3():S3-S17. PubMed ID: 19963098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
    Corradetti MN; Guan KL
    Oncogene; 2006 Oct; 25(48):6347-60. PubMed ID: 17041621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin (mTOR) pathway signalling in lymphomas.
    Drakos E; Rassidakis GZ; Medeiros LJ
    Expert Rev Mol Med; 2008 Feb; 10():e4. PubMed ID: 18241520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mammalian target of rapamycin pathway and its role in molecular nutrition regulation.
    Lian J; Yan XH; Peng J; Jiang SW
    Mol Nutr Food Res; 2008 Apr; 52(4):393-9. PubMed ID: 18306429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells.
    Paglin S; Lee NY; Nakar C; Fitzgerald M; Plotkin J; Deuel B; Hackett N; McMahill M; Sphicas E; Lampen N; Yahalom J
    Cancer Res; 2005 Dec; 65(23):11061-70. PubMed ID: 16322256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.
    Frias MA; Thoreen CC; Jaffe JD; Schroder W; Sculley T; Carr SA; Sabatini DM
    Curr Biol; 2006 Sep; 16(18):1865-70. PubMed ID: 16919458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1.
    Rosner M; Hengstschläger M
    Hum Mol Genet; 2008 Oct; 17(19):2934-48. PubMed ID: 18614546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin is a neuroprotective treatment for traumatic brain injury.
    Erlich S; Alexandrovich A; Shohami E; Pinkas-Kramarski R
    Neurobiol Dis; 2007 Apr; 26(1):86-93. PubMed ID: 17270455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth.
    Yang X; Yang C; Farberman A; Rideout TC; de Lange CF; France J; Fan MZ
    J Anim Sci; 2008 Apr; 86(14 Suppl):E36-50. PubMed ID: 17998426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway.
    Sobolewska A; Gajewska M; Zarzyńska J; Gajkowska B; Motyl T
    Eur J Cell Biol; 2009 Feb; 88(2):117-30. PubMed ID: 19013662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding mTOR signaling.
    Yang Q; Guan KL
    Cell Res; 2007 Aug; 17(8):666-81. PubMed ID: 17680028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells.
    Hashimoto I; Koizumi K; Tatematsu M; Minami T; Cho S; Takeno N; Nakashima A; Sakurai H; Saito S; Tsukada K; Saiki I
    Eur J Cancer; 2008 May; 44(7):1022-9. PubMed ID: 18375114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mammalian target of rapamycin, its mode of action and clinical response in metastatic clear cell carcinoma].
    Shuuin T; Karashima H
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1076-9. PubMed ID: 19620795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
    Iwamaru A; Kondo Y; Iwado E; Aoki H; Fujiwara K; Yokoyama T; Mills GB; Kondo S
    Oncogene; 2007 Mar; 26(13):1840-51. PubMed ID: 17001313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic suppression of colorectal cancer cell growth by the dual mTORC1 and mTORC2 inhibitor AZD-2014.
    Huo HZ; Zhou ZY; Wang B; Qin J; Liu WY; Gu Y
    Biochem Biophys Res Commun; 2014 Jan; 443(2):406-12. PubMed ID: 24309100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3.
    Busch S; Renaud SJ; Schleussner E; Graham CH; Markert UR
    Exp Cell Res; 2009 Jun; 315(10):1724-33. PubMed ID: 19331815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian target of rapamycin and the kidney. I. The signaling pathway.
    Lieberthal W; Levine JS
    Am J Physiol Renal Physiol; 2012 Jul; 303(1):F1-10. PubMed ID: 22419691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
    Gorshtein A; Rubinfeld H; Kendler E; Theodoropoulou M; Cerovac V; Stalla GK; Cohen ZR; Hadani M; Shimon I
    Endocr Relat Cancer; 2009 Sep; 16(3):1017-27. PubMed ID: 19509067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.